Literature DB >> 24602759

Follicular lymphoma: watch and wait is watch and worry.

Stephen M Ansell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24602759     DOI： 10.1016/S1470-2045(14)70066-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

Review 1.  Nature and importance of follicular lymphoma precursors.

Authors:  Emilie Mamessier; Florence Broussais-Guillaumot; Bruno Chetaille; Reda Bouabdallah; Luc Xerri; Elaine S Jaffe; Bertrand Nadel
Journal:  Haematologica       Date:  2014-05       Impact factor: 9.941

2.  The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma.

Authors:  Joanna M Davies; Thomas R Osborne; Polly M Edmonds; Steve A Schey; Steve Devereux; Irene J Higginson; Christina Ramsenthaler
Journal:  Eur J Haematol       Date:  2017-03-09       Impact factor: 2.997

3.  Durable Complete Remission and Long-Term Survival in FDG-PET Staged Patients with Stage III Follicular Lymphoma, Treated with Wide-Field Radiation Therapy.

Authors:  Michael P MacManus; Rodney J Hicks; Mathias Bressel; Belinda A Campbell; Andrew Wirth; Gail Ryan; H Miles Prince; Max Wolf; Rachel Brown; John F Seymour
Journal:  Cancers (Basel)       Date:  2020-04-17       Impact factor: 6.639

4.  Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

Authors:  Raphael Mwangi; Stephen M Ansell; Thomas M Habermann; James R Cerhan; Christopher Strouse; Brian K Link; Yucai Wang; Rebecca L King; William R Macon; J C Villasboas; Thomas E Witzig; Matthew J Maurer; Grzegorz S Nowakowski
Journal:  Blood Cancer J       Date:  2021-07-17       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.